Hoppa till innehållet
Radio Logo

Lung Cancer Update

Dr. Neil Love
Senaste avsnittet

66 avsnitt

  • Lung Cancer Update

    Non-Small Cell Lung Cancer — A Presentation by Dr Julia Rotow on the Potential Role of PD-1 x VEGF Bispecific Antibodies

    2026-10-17 | 24 min.
    Featuring a slide presentation from Dr Julia Rotow, including the following topics:
    Rationale and potential clinical role of PD-1/PD-L1 x vascular endothelial growth factor (VEGF) bispecific antibodies in the treatment of non-small cell lung cancer (NSCLC) (0:00)
    Key findings from the Phase III HARMONi-6 study; ongoing Phase III HARMONi-3 study (5:12)
    Key findings from the Phase III HARMONi-2 study; ongoing Phase III HARMONi-7 study (9:59)
    Clinician insights about the potential role of ivonescimab in the front-line setting (12:02)
    Impetus for investigating ivonescimab in the relapsed/refractory (R/R) EGFR-mutant setting (14:01)
    Key findings from the Phase III HARMONi-A and HARMONi studies (16:07)
    Clinician insights about the potential role of ivonescimab in the treatment of R/R EGFR-mutant NSCLC; other novel PD-1/PD-L1 x VEGF bispecific antibodies under investigation (20:30)

    CME information and select publications
  • Lung Cancer Update

    Lung Cancer — Proceedings from a Symposium Held in Conjunction with the American Oncology Network

    2026-10-04 | 50 min.
    Featuring perspectives from Dr Stephen V Liu and Dr Stephen "Fred" Divers, moderated by Dr Divers, including the following topics:
    Introduction (0:00)
    EGFR Mutations (2:23)
    HER2 Alterations (22:40)
    Available and Investigational Immunotherapies (32:14)
    Small Cell Lung Cancer (40:48)

    CME information and select publications
  • Lung Cancer Update

    For Oncology Nurses: Non-Small Cell Lung Cancer with a ROS1 Fusion — An Interview with Dr Alexander E Drilon

    2026-09-30 | 58 min.
    Featuring an interview with Dr Alexander E Drilon, including the following topics:
    Overview of targetable biomarkers in lung cancer (0:00)
    Biomarker testing for genomic alterations in lung cancer (5:24)
    Overview of ROS1 alterations in lung cancer (13:44)
    Efficacy data with ROS1 inhibitors for lung cancer (17:02)
    Safety data with ROS1 inhibitors for lung cancer (21:15)
    Case: A woman in her early 50s with a history of non-small cell lung cancer (NSCLC) undergoes biomarker testing to reveal a ROS1 fusion (28:56)
    Case: A man in his late teens diagnosed with de novo advanced NSCLC with a ROS1 alteration achieves a dramatic response to therapy (46:16)
    Case: A woman in her early 60s with a history of ROS1-altered NSCLC receives several ROS1 inhibitors (50:52)

    NCPD information and select publications
  • Lung Cancer Update

    Non-Small Cell Lung Cancer — Targeting KRAS G12C

    2026-09-10 | 57 min.
    Featuring perspectives from Prof Solange Peters and Dr Joshua K Sabari, including the following topics:
    Introduction (0:00)
    Best Option for Your Patient (1:28)
    Biological Considerations (6:26)
    KRAS G12C Inhibitors (11:33)
    Second-Line Treatment (13:02)
    Current Clinical Trials in the First-Line Metastatic Setting (32:18)
    Current Clinical Trials in the Localized Setting (49:52)
    Current Clinical Trials with New Treatment Combinations and Agents (53:51)

    CME information and select publications
  • Lung Cancer Update

    Lambert-Eaton Myasthenic Syndrome in Small Cell Lung Cancer — An Interview with Prof Ticiana Leal

    2026-09-01 | 54 min.
    Featuring an interview with Prof Ticiana Leal, including the following topics:
    Pathophysiology and clinical signs and symptoms (0:00)
    Screening and/or diagnostic approaches (5:45)
    Potential impact of available therapies for small cell lung cancer (SCLC) on paraneoplastic syndromes (7:36)
    Key clinical trial data for amifampridine and practicalities of its administration (14:05)
    Building awareness among patients, caregivers and the oncology community (22:37)
    Role of pyridostigmine in managing Lambert-Eaton myasthenic syndrome (LEMS); potential integration of EMG (electromyography) into monitoring (25:35)
    Case: A man in his early 70s who receives a diagnosis of limited-stage SCLC (LS-SCLC) with LEMS and undergoes treatment (27:41)
    Case: A woman in her late 70s already diagnosed with LS-SCLC who is subsequently evaluated and treated for LEMS (37:55)
    Current research and potential developments in the treatment of SCLC (48:32)

    CME information and select publications
Fler podcasts i Hälsa och motion
Om Lung Cancer Update
Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing medical oncologists, hematologists and hematology/oncology fellows ongoing access to the perspectives and opinions of national and international research leaders with an expertise in thoracic oncology.
Podcast-webbplats

Lyssna på Lung Cancer Update, Bara En Till... - Om beroende & medberoende och många andra poddar från världens alla hörn med radio.se-appen

Hämta den kostnadsfria radio.se-appen

  • Bokmärk stationer och podcasts
  • Strömma via Wi-Fi eller Bluetooth
  • Stödjer Carplay & Android Auto
  • Många andra appfunktioner
Lung Cancer Update: Poddsändningar i Familj
Sociala nätverk
v8.27.0 | © 2007-2026 radio.de GmbH
Built: 11/16/2026 - 1:18:40 PM